Bronchiectasis in Adults: Aetiology and New Therapies
Funding
Conflicts of Interest
References
- Aliberti, S.; Masefield, S.; Polverino, E.; de Soyza, A.; Loebinger, M.R.; Menendez, R.; Ringshausen, F.C.; Vendrell, M.; Powell, P.; Chalmers, J.D. Research priorities in bronchiectasis: A consensus statement from the EMBARC Clinical Research Collaboration. Eur. Respir. J. 2016, 48, 632–647. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dhar, R.; Singh, S.; Talwar, D.; Mohan, M.; Tripathi, S.K.; Swarnakar, R.; Trivedi, S.; Rajagopala, S.; D’Souza, G.; Padmanabhan, A.; et al. Bronchiectasis in India: Results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry. Lancet Glob. Health 2019, 7, e1269–e1279. [Google Scholar] [CrossRef]
- Aksamit, T.R.; O’Donnell, A.E.; Barker, A.; Olivier, K.N.; Winthrop, K.L.; Daniels, M.L.A.; Johnson, M.; Eden, E.; Griffith, D.; Knowles, M.; et al. Adult Patients with Bronchiectasis: A First Look at the US Bronchiectasis Research Registry. Chest 2017, 151, 982–992. [Google Scholar] [CrossRef] [PubMed]
- Visser, S.K.; Bye, P.T.P.; Fox, G.J.; Burr, L.D.; Chang, A.B.; Holmes-Liew, C.; King, P.; Middleton, P.G.; Maguire, G.P.; Smith, D.; et al. Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis Registry. Respir. Med. 2019, 155, 97–103. [Google Scholar] [CrossRef] [PubMed]
- Martinez-Garcia, M.A.; de la Rosa Carrillo, D.; Soler-Cataluna, J.J.; Donat-Sanz, Y.; Serra, P.C.; Lerma, M.A.; Ballestín, J.; Sánchez, I.V.; Ferrer, M.J.S.; Dalfo, A.R.; et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2013, 187, 823–831. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Choi, H.; Lee, H.; Ra, S.W.; Kim, H.K.; Lee, J.S.; Um, S.-J.; Kim, S.-H.; Oh, Y.-M.; Kwon, Y.-S.; on behalf of the KMBARC. Clinical Characteristics of Patients with Post-Tuberculosis Bronchiectasis: Findings from the KMBARC Registry. J. Clin. Med. 2021, 10, 4542. [Google Scholar] [CrossRef]
- Dettmer, S.; Ringshausen, F.C.; Fuge, J.; Maske, H.L.; Welte, T.; Wacker, F.; Rademacher, J. Computed Tomography in Adults with Bronchiectasis and Nontuberculous Mycobacterial Pulmonary Disease: Typical Imaging Findings. J. Clin. Med. 2021, 10, 2736. [Google Scholar] [CrossRef]
- Cole, P.J. Inflammation: A two-edged sword—The model of bronchiectasis. Eur. J. Respir. Dis. Suppl. 1986, 147, 6–15. [Google Scholar] [PubMed]
- Qin, L.; Guitart, M.; Admetlló, M.; Esteban-Cucó, S.; Maiques, J.M.; Xia, Y.; Zha, J.; Carbullanca, S.; Duran, X.; Wang, X.; et al. Do Redox Balance and Inflammatory Events Take Place in Mild Bronchiectasis? A Hint to Clinical Implications. J. Clin. Med. 2021, 10, 4534. [Google Scholar] [CrossRef] [PubMed]
- King, P.T.; Holdsworth, S.R.; Freezer, N.J.; Villanueva, E.; Gallagher, M.; Holmes, P.W. Outcome in adult bronchiectasis. COPD 2005, 2, 27–34. [Google Scholar] [CrossRef] [PubMed]
- Qin, L.; Gonçalves-Carvalho, F.; Xia, Y.; Zha, J.; Admetlló, M.; Maiques, J.M.; Esteban-Cucó, S.; Duran, X.; Marín, A.; Barreiro, E. Profile of Clinical and Analytical Parameters in Bronchiectasis Patients during the COVID-19 Pandemic: A One-Year Follow-Up Pilot Study. J. Clin. Med. 2022, 11, 1727. [Google Scholar] [CrossRef]
- Adeloye, D.; Elneima, O.; Daines, L.; Poinasamy, K.; Quint, J.K.; Walker, S.; Brightling, C.E.; Siddiqui, S.; Hurst, J.R.; Chalmers, J.D.; et al. The long-term sequelae of COVID-19: An international consensus on research priorities for patients with pre-existing and new-onset airways disease. Lancet Respir. Med. 2021, 9, 1467–1478. [Google Scholar] [CrossRef]
- Lee, A.L.; Burge, A.T.; Holland, A.E. Airway clearance techniques for bronchiectasis. Cochrane Database Syst. Rev. 2015, 5, CD008351. [Google Scholar] [CrossRef] [PubMed]
- Lee, A.L.; Tilley, L.; Baenziger, S.; Hoy, R.; Glaspole, I. The Perceptions of Telehealth Physiotherapy for People with Bronchiectasis during a Global Pandemic—A Qualitative Study. J. Clin. Med. 2022, 11, 1315. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
King, P.T.; Morgan, L. Bronchiectasis in Adults: Aetiology and New Therapies. J. Clin. Med. 2022, 11, 5957. https://doi.org/10.3390/jcm11195957
King PT, Morgan L. Bronchiectasis in Adults: Aetiology and New Therapies. Journal of Clinical Medicine. 2022; 11(19):5957. https://doi.org/10.3390/jcm11195957
Chicago/Turabian StyleKing, Paul T., and Lucy Morgan. 2022. "Bronchiectasis in Adults: Aetiology and New Therapies" Journal of Clinical Medicine 11, no. 19: 5957. https://doi.org/10.3390/jcm11195957